Key Highlights
- Rivian shares declined approximately 4% in premarket hours Friday following Q1 results that surpassed analyst expectations
- First-quarter revenue reached $1.38B, climbing 11% year-over-year; EPS loss of $0.33 significantly outperformed the $0.72 consensus
- R2 vehicle production commenced at the Normal, Illinois facility; deliveries to customers anticipated “later this spring”
- Department of Energy loan adjusted downward from $6.6B to approximately $4.5B, while Georgia manufacturing facility capacity expanded 50% to 300,000 vehicles
- Market skeptic questions RIVN’s $20B valuation given unverified R2 market demand
Shares of Rivian (RIVN) fell roughly 4% during premarket hours on Friday following the electric vehicle manufacturer’s first-quarter 2026 financial release. The stock settled at $16.40 during Wednesday’s close before declining to $15.76 in early Friday sessions.
The financial performance exceeded Wall Street’s more pessimistic projections. First-quarter revenue totaled $1.38 billion, representing an 11% increase from the prior year period. The company’s loss per share of $0.33 significantly outperformed analyst estimates calling for a $0.72 loss.
The automaker achieved gross profit of $119 million, marking the third straight quarter of positive gross margins. Particularly noteworthy was the software and services division, which generated $180 million in gross profit—approximately 60% above last year’s figure.
However, adjusted EBITDA remained negative at $472 million. The path to overall profitability remains a work in progress, a reality not lost on market participants.
Rivian manufactured 10,236 vehicles while delivering 10,365 units during the first quarter. Management reaffirmed its 2026 annual delivery projection of 62,000 to 67,000 vehicles.
The eagerly anticipated R2 model has entered production at the company’s Normal, Illinois manufacturing site. Chief Executive RJ Scaringe indicated customer deliveries would commence “later this spring,” with substantial volume acceleration expected during the third and fourth quarters.
“With the increase in volume, you have more fixed cost absorption, so the cost of goods sold will come down meaningfully,” Scaringe explained. “The margin structure will start to shine through.”
Expanded Capacity for Georgia Manufacturing Facility
Rivian revealed updated specifications for its forthcoming Georgia production complex. Initial manufacturing capacity will expand 50% to accommodate 300,000 vehicles annually, with groundbreaking scheduled for 2026.
The Department of Energy financing package supporting the project has been recalibrated from $6.6 billion to roughly $4.5 billion. Importantly, Rivian will begin accessing these funds in 2027, accelerating the previous 2028 schedule.
“Accessing those dollars sooner and faster is going to be helpful to get more capacity, more volume sooner,” Scaringe noted. Following Phase 1 completion, Rivian projects total production capacity exceeding 500,000 units—a threshold the CEO believes enables positive free cash flow generation.
Cash Position Remains Solid Despite Skeptical Voices
The company concluded the first quarter holding $4.83 billion in cash reserves and $5.39 billion in overall liquidity, decreasing from $6.59 billion at year-end. The reduction mirrors continued capital deployment as operations expand.
Scaringe highlighted a comprehensive liquidity position totaling $13.6 billion when factoring in the Volkswagen joint venture funding, the Uber partnership, and the DOE credit facility. In early 2026, Rivian secured an additional $1 billion from Volkswagen following successful validation of the VW ID.EVERY1, which incorporates Rivian’s software architecture and platform technology.
The Uber collaboration, revealed in March, commits Rivian to providing up to 50,000 autonomous-ready R2 electric vehicles in return for $1.25 billion in capital.
Not all observers share management’s optimism. Investment analyst ValueAnalyst maintains a Sell recommendation, contending the $20 billion market capitalization already assumes R2 commercial success—despite critical specifications like range and final pricing remaining undisclosed. Those details won’t materialize until late 2027, while short interest currently represents over 11% of shares outstanding.
Wall Street maintains a Moderate Buy consensus rating, comprised of 10 Buy recommendations, 8 Hold ratings, and 4 Sell opinions. The mean 12-month price target stands at $17.91.





